Disclaimer

You are currently seeing Indegene's Brand New Investor Relations Website. Indegene Limited, a listed entity on NSE and BSE, India, has made every effort to ensure the accuracy and completeness of the information provided in the Investors section. During the transition to our new website, some documents or content may have been inadvertently omitted or not updated.

Visitors are encouraged to verify the latest information through official filings on NSE and BSE or by contacting our Investor Relations team. Thank you for your patience.

Company Overview

We help biopharmaceutical, emerging biotech and medical device companies develop products, get them to the market, and grow their impact
through the life cycle in a more effective, efficient, and modern way. We bring together healthcare domain expertise, fit-for-purpose
technology, and an agile operating model to provide a diverse range of solutions. These aim to deliver, amongst other outcomes, a
personalized, scalable and omnichannel experience for patients and physicians. It’s what drives our team and our purpose to enable healthcare
organizations to be future ready.

Company Announcements
Q3 FY24-25 Quarterly Results
Revenue

₹ 7,204 Mn

YoY Revenue Growth

7.0%

PAT

₹ 1,097 Mn

YoY PAT Growth

11.1%

Total Employees

4,880

Healthcare Expertise

23.3%

Voluntary Attrition (LTM)

17.3%

Women Employees

45.0%